Research

Bone health in patients with brain tumors. - University of Virginia study. Patients with brain cancer are susceptible to bone diseases and can be treated with the same drugs used for osteoporosis.

Biologicals in osteoporosis: teriparatide and parathyroid hormone in women and men.

Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate. - A study of limited scope suggests that teriparatide may be less effective when patienrs have previously taken bisphosphonate drugs (alendronate or risedronate).

Orthopedic uses of teriparatide

Short-term teriparatide delivery and osseointegration: a clinical feasibility study - the effects of teriparatide on the osseointegration of titanium implants.

Prescription drug therapies for prevention and treatment of postmenopausal osteoporosis. - overview of medications used for osteoporosis. Concludes they are mostly safe.

Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis.

Effects of parathyroid hormone (teriparatide) on bone mass and quality in osteoporosis - Japanese study

The Effect of Teriparatide [Human Parathyroid Hormone (1-34)] Therapy on Bone Density in Men With Osteoporosis - From the Journal of Bone and Mineral Research. Found teriparatide increased spinal and femoral bone mass densities.

Unigene Regains Oral rPTH Osteoporosis Candidate from GSK - about an oral recombinant parathyroid hormone (rPTH) candidate

Other Resources

National Institute of Arthritis and Musculoskeletal Skin Diseases

Profile of teriparatide in the management of postmenopausal osteoporosis